NCT02231346已完成不适用
Berodual® Respimat® 20/50 Microgram/Dose Solution for Inhalation: Assessment of Handling and Patient Satisfaction in Comparison to a Powder Inhaler
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
- 主要终点
- Number of patients with adverse events
研究概览
简要总结
New perceptions about handling and patient satisfaction of the everyday use of Berodual® Respimat® compared to a powder inhaler in patients with chronic obstructive lung disease (COLD). Moreover, further knowledge should be attained about the tolerability of Berodual® Respimat®
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female patients aged at least 18 years
- •Patients who are suffering from symptoms of a chronic obstructive lung disease (COLD) can be included in the PMS. To reduce influences caused by the use of a variety of different powder inhaler, only patients who are already regularly using Diskus® powder inhaler should be included, as the Diskus® as well as the Berodual® Respimat® are multiple dose devices
- •During the PMS the Diskus® therapy is to be continued
排除标准
- •Patients who meet one or more of the general or specific contraindications mentioned in the Summary of Product Characteristics (SmPC) are excluded from the Postmarketing Surveillance (PMS)
研究组 & 干预措施
chronic obstructive pulmonary disease patients
干预措施: Berodual® Respimat® - inhaler (Drug)
结局指标
主要结局
Number of patients with adverse events
时间窗: up to 4 weeks
Number of patients who prematurely discontinued therapy with Berodual® Respimat®
时间窗: up to 4 weeks
次要结局
- Assessment of patient satisfaction with regard to handling of Berodual® Respimat® inhaler(up to 4 weeks)
- Assessment of patient satisfaction with regard to handling of Diskus® inhaler(Baseline)
研究者
相似试验
已完成
不适用
Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT02231320Boehringer Ingelheim236
已完成
不适用
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways DiseasePulmonary Disease, Chronic ObstructiveNCT02231372Boehringer Ingelheim4,602
已完成
不适用
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways DiseasePulmonary Disease, Chronic ObstructiveNCT02231359Boehringer Ingelheim2,006
已完成
3 期
Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed ConditionPulmonary Disease, Chronic ObstructiveAsthmaNCT02173795Boehringer Ingelheim245
已完成
4 期
Investigation of patient satisfaction and efficacy of Dovobet Gel in psoriasis patients with poor adherencePlaque PsoriasisJPRN-jRCTs031180049akagawa Hidemi46